Drug Recalls Center
2,090 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Important Medication Safety Information
- Do not stop taking prescribed medications without consulting your healthcare provider
- Contact your pharmacist or doctor if you have a recalled medication
- Check lot numbers carefully - not all batches may be affected
- Return recalled medications to your pharmacy for proper disposal
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
Teva Octreotide Acetate Injectable Suspension Recall 19,869 Cartons Nationwide (2026)
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Teva Octreotide Acetate Injectable Suspension Recall Expanded in 2026 for Sterility Concerns
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials, Rx only, nephron 503B Outsourcing facility, 4600 12th Street Extension, West Columbia, SC 29172,...
Xanax XR Alprazolam Recall Over Failed Dissolution Specifications Affects US Nationwide Distribution
Meclizine Hydrochloride Tablets Recalled for Failed Specifications (2026) 697 Cartons Nationwide
Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300,...
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Cipla USA Lanreotide Injection Recall for Sterility Assurance Issue (2026)
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Lanreotide Injection recall: Cipla USA lanreotide acetate pre-filled syringes recalled for sterility
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.
Presence of particulate matter: identified as Buprenorphine free base
Brahms PlGF Plus KRYPTOR 859075N Recall Expands to 5,254 Units Worldwide (2026)
Stryker Sustainability Solutions Color Cuff Recall Expands to 56,740 Cuffs Over Detachment Risk (202
Due to potential for tourniquet cuffs to detach from the bladder at the welding connection and result in the cuff not being able to maintain pressure.
0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 600047, Unit of Use...
Lack of Assurance of Sterility
0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius...
Lack of Assurance of Sterility
Fresenius Kabi 5% Dextrose Injection Recall for Sterility Concerns (2026) Affecting US Nationwide, R
Lack of Assurance of Sterility
Fresenius Kabi 0.9% Sodium Chloride Injection Recalled for Lack of Sterility Assurance (2026)
Lack of Assurance of Sterility
Fresenius Kabi 0.9% Sodium Chloride Injection Recalled for Lack of Sterility Assurance
Fresenius Kabi USA recalls 0.9% Sodium Chloride Injection units distributed nationwide, including Alaska and Puerto Rico. The recall cites lack of assurance of sterility. Healthcare providers should stop use and contact Fresenius Kabi for guidance.
BD and Fresenius Kabi 1,000 mL Sodium Chloride Injection Recall for Sterility Concerns (2026)
Lack of Assurance of Sterility
Fresenius Kabi Saline Solution Recalled for Lack of Sterility Assurance (2026)
Lack of Assurance of Sterility
BD and Fresenius Kabi Sodium Chloride Injection Recalled for Lack of Sterility Assurance (2026)
Lack of Assurance of Sterility
0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use...
Lack of Assurance of Sterility
0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex bag, 500 mL x 20, Manufactured for: Fresenius Kabi USA, LLC ("Fresenius Kabi"), IL 60047, Unit of...
Lack of Assurance of Sterility
Get Drug Recall Alerts
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.